Literature DB >> 4926242

Clinical studies with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037).

H H Hansen, O S Selawry, F M Muggia, M D Walker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4926242

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  14 in total

1.  Letter: CCNU in teatment of recurrent medulloblastoma.

Authors:  H W Ward
Journal:  Br Med J       Date:  1974-03-30

2.  Distribution of Bratton-Marshall-positive material in mice following intravenous injections of nitrosoureas.

Authors:  P Kari; W R McConnell; J M Finkel; D L Hill
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  Increased degradation rate of nitrososureas in media containing carbonate.

Authors:  Janeric Seidegård; Lena Grönquist; Helen Tuvesson; Per-Olov Gunnarsson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-10-15       Impact factor: 2.416

4.  Multidisciplinary treatment for central nervous system tumours with nitrosourea compounds.

Authors:  P Paoletti; G Robustelli della Cuna; R Knerich; M R Strada
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

5.  Antitumor activity of a nitrosourea derivative, CNUA, on murine tumors.

Authors:  K Edanami; K Komiyama; T Kuroda; I Umezawa
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

6.  Chemotherapy of malignant gliomas: comparison of the effect of polychemo- and CCNU-therapy.

Authors:  W D Heiss
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

7.  Anti-tumour, toxicological and pharmacokinetic properties of a novel taurine-based nitrosourea (TCNU).

Authors:  B Hartley-Asp; P I Christensson; K Gunnarsson; P O Gunnarsson; G Jensen; J Polacek; A Stamvik
Journal:  Invest New Drugs       Date:  1988-04       Impact factor: 3.850

8.  Chlorozotocin, an anti-tumour agent lacking bone marrow toxicity at therapeutic doses: effects on lymphocyte subpopulations in mice.

Authors:  R I Fisher; G L Mandell; F Bostick; M G McMenamin; T Anderson
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

9.  Pharmacokinetics and cytotoxicity of B.3839, a molecular combination of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea, in a mouse model.

Authors:  P M Loadman; M C Bibby; J A Double; R S McElhinney
Journal:  Invest New Drugs       Date:  1992-08       Impact factor: 3.850

10.  CCNU in combination chemotherapy for advanced histologically unfavorable non-Hodgkin's lymphoma.

Authors:  D V Jackson; H B Muss; F Richards; D R White; C L Spurr; M R Cooper; R M Christian; T F Trahey; L D Case; H B Wells
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.